Medacta Group SA

Medacta announces the 10th M.O.R.E. International Symposium in Lugano, Switzerland, celebrating its 25th anniversary worldwide

Medacta publishes 2024 Annual General Meeting invitation

Medacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023

Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024

Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023

Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)

A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application

Medacta further expands in Rancate, Switzerland, doubling its production capability to support the future growth

Medacta Announces the Launch of GMK SpheriKA, the World’s First Knee Implant Optimized for Kinematic Alignment (KA)

A new study confirms the accuracy of NextAR Shoulder, Medacta’s augmented reality surgical application

Medacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023

Medacta Group SA: 2023 Half-Year Unaudited Top-Line Figures

Medacta is pleased to announce the first European Peri-Acetabular Osteotomy procedures using the MyPAO Platform, a unique solution for acetabular realignment

Medacta showcases NextAR Spine MIS LT procedure at Spine Week, efficiently complementing operative workflow for spine surgery

Medacta Group SA: Medacta announces the results of today’s Annual General Meeting

Medacta’s P-Family Hip System offering is now more complete with the introduction of the new SMS Collared Stem

Medacta Celebrates Expansion into New Distribution Facility in the US

Medacta publishes 2023 Annual General Meeting invitation

New clinical study demonstrates Medacta’s MySpine accuracy in screw replacement during spine revision surgery

Medacta Group SA: 2022 Full Year Results

Medacta to Showcase MyKA Kinematic Alignment Platform and NextAR Augmented Reality Surgical Platform at AAOS 2023

Medacta Group SA: 2022 Full Year Unaudited Top-Line Figures release / Today’s call at 4:00pm CET

Medacta Group SA: First NextAR surgeries in Japan with the award-winning NextAR Augmented Reality Surgical Platform

Medacta Group SA announces the final settlement in the Conformis case

Medacta Group SA: Medacta Expands its Hip Offerings with New Cobalt-Free SensiTiN™ Double Mobility Converter

Medacta NextAR Spine wins the 2022 Spine Technology Award from Orthopedics This Week during North American Spine Society Annual Meeting

Medacta announces the first MySpine Anchor procedure completed in the US

Medacta announces first revision surgeries in the US using the unique-on-the-market and innovative MyKnee R patient-specific solution

Medacta Group SA reports strong revenue growth of 19.0% and adjusted EBITDA margin of 27.5% in the first semester 2022

Medacta Group SA reports 19.0% growth of half-year revenue